Find link

language: af: Afrikaans als: Alemannisch [Alemannic] am: አማርኛ [Amharic] an: aragonés [Aragonese] ar: العربية [Arabic] arz: مصرى [Egyptian Arabic] as: অসমীয়া [Assamese] ast: asturianu [Asturian] az: azərbaycanca [Azerbaijani] azb: تۆرکجه [Southern Azerbaijani] ba: башҡортса [Bashkir] bar: Boarisch [Bavarian] bat-smg: žemaitėška [Samogitian] be: беларуская [Belarusian] be-tarask: беларуская (тарашкевіца) [Belarusian (Taraškievica)] bg: български [Bulgarian] bn: বাংলা [Bengali] bpy: বিষ্ণুপ্রিয়া মণিপুরী [Bishnupriya Manipuri] br: brezhoneg [Breton] bs: bosanski [Bosnian] bug: ᨅᨔ ᨕᨘᨁᨗ [Buginese] ca: català [Catalan] ce: нохчийн [Chechen] ceb: Cebuano ckb: کوردیی ناوەندی [Kurdish (Sorani)] cs: čeština [Czech] cv: Чӑвашла [Chuvash] cy: Cymraeg [Welsh] da: dansk [Danish] de: Deutsch [German] el: Ελληνικά [Greek] en: English eo: Esperanto es: español [Spanish] et: eesti [Estonian] eu: euskara [Basque] fa: فارسی [Persian] fi: suomi [Finnish] fo: føroyskt [Faroese] fr: français [French] fy: Frysk [West Frisian] ga: Gaeilge [Irish] gd: Gàidhlig [Scottish Gaelic] gl: galego [Galician] gu: ગુજરાતી [Gujarati] he: עברית [Hebrew] hi: हिन्दी [Hindi] hr: hrvatski [Croatian] hsb: hornjoserbsce [Upper Sorbian] ht: Kreyòl ayisyen [Haitian] hu: magyar [Hungarian] hy: Հայերեն [Armenian] ia: interlingua [Interlingua] id: Bahasa Indonesia [Indonesian] io: Ido is: íslenska [Icelandic] it: italiano [Italian] ja: 日本語 [Japanese] jv: Basa Jawa [Javanese] ka: ქართული [Georgian] kk: қазақша [Kazakh] kn: ಕನ್ನಡ [Kannada] ko: 한국어 [Korean] ku: Kurdî [Kurdish (Kurmanji)] ky: Кыргызча [Kirghiz] la: Latina [Latin] lb: Lëtzebuergesch [Luxembourgish] li: Limburgs [Limburgish] lmo: lumbaart [Lombard] lt: lietuvių [Lithuanian] lv: latviešu [Latvian] map-bms: Basa Banyumasan [Banyumasan] mg: Malagasy min: Baso Minangkabau [Minangkabau] mk: македонски [Macedonian] ml: മലയാളം [Malayalam] mn: монгол [Mongolian] mr: मराठी [Marathi] mrj: кырык мары [Hill Mari] ms: Bahasa Melayu [Malay] my: မြန်မာဘာသာ [Burmese] mzn: مازِرونی [Mazandarani] nah: Nāhuatl [Nahuatl] nap: Napulitano [Neapolitan] nds: Plattdüütsch [Low Saxon] ne: नेपाली [Nepali] new: नेपाल भाषा [Newar] nl: Nederlands [Dutch] nn: norsk nynorsk [Norwegian (Nynorsk)] no: norsk bokmål [Norwegian (Bokmål)] oc: occitan [Occitan] or: ଓଡ଼ିଆ [Oriya] os: Ирон [Ossetian] pa: ਪੰਜਾਬੀ [Eastern Punjabi] pl: polski [Polish] pms: Piemontèis [Piedmontese] pnb: پنجابی [Western Punjabi] pt: português [Portuguese] qu: Runa Simi [Quechua] ro: română [Romanian] ru: русский [Russian] sa: संस्कृतम् [Sanskrit] sah: саха тыла [Sakha] scn: sicilianu [Sicilian] sco: Scots sh: srpskohrvatski / српскохрватски [Serbo-Croatian] si: සිංහල [Sinhalese] simple: Simple English sk: slovenčina [Slovak] sl: slovenščina [Slovenian] sq: shqip [Albanian] sr: српски / srpski [Serbian] su: Basa Sunda [Sundanese] sv: svenska [Swedish] sw: Kiswahili [Swahili] ta: தமிழ் [Tamil] te: తెలుగు [Telugu] tg: тоҷикӣ [Tajik] th: ไทย [Thai] tl: Tagalog tr: Türkçe [Turkish] tt: татарча/tatarça [Tatar] uk: українська [Ukrainian] ur: اردو [Urdu] uz: oʻzbekcha/ўзбекча [Uzbek] vec: vèneto [Venetian] vi: Tiếng Việt [Vietnamese] vo: Volapük wa: walon [Walloon] war: Winaray [Waray] yi: ייִדיש [Yiddish] yo: Yorùbá [Yoruba] zh: 中文 [Chinese] zh-min-nan: Bân-lâm-gú [Min Nan] zh-yue: 粵語 [Cantonese]

jump to random article

searching for Sanofi 234 found (1265 total)

alternate case: sanofi

Team Novo Nordisk (1,380 words) [view diff] exact match in snippet view article find links to article

history 2008–2010 2011 2011–2012 2013– Team Type 1 (TT1) Team Type 1–Sanofi Aventis (TT1) Team Type 1–Sanofi (TT1) Team Novo Nordisk (TNN) Current season

Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that

approved for use in the United States in December 1999. Insulin lispro Sanofi was granted marketing authorization as a biosimilar in the European Union

December 2022. CYD-TDV, sold under the brand name Dengvaxia and made by Sanofi Pasteur, is a live attenuated tetravalent vaccine that is administered as

muscle relaxant called Décontractyl but was taken out of production by Sanofi Aventis and due to a French Health Ministry decree in July 2019. Mephenesin

barbiturate derivative. It was developed by Poulenc Brothers (now part of Sanofi) in 1921. International Drug Names Nordegren T (2002). "Butobarbital". The

American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In

thereby preventing the activation of the receptor. This drug was developed by Sanofi/Merrimack Pharmaceuticals, Inc. World Health Organization (2012). "International

marketed in the USA are Kinrix from GlaxoSmithKline and Quadracel from Sanofi Pasteur. Repevax is available in the UK. Within Japan, the formulation is

natural molecules for crop protection. In 2012, it formed a partnership with Sanofi Genzyme to develop a treatment for transthyretin-mediated amyloidosis, a

barring Regeneron and Sanofi from marketing alirocumab, which was granted in January 2017. The judge gave Regeneron and Sanofi 30 days to appeal before

cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-193 has a binding affinity at the CB1 receptor

rode professionally between 2008 and 2021 for the Cofidis, Team Type 1–Sanofi, Sojasun, Nippo–Delko–One Provence and EF Education–Nippo teams. During

aggressive form of depression that resulted in death by suicide for some. The Sanofi laboratory, despite knowing its side effects, allowed women to continue

Winner  Alexander Efimkin (RUS) (Team Type 1–Sanofi Aventis)   Second  Andrey Zeits (KAZ) (Astana)   Third  Thibaut Pinot (FRA) (FDJ) Points  Alessandro

cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-198 has a binding affinity at the CB1 receptor

2000 under the trade name "Rovamycine", produced by Rhone-Poulenc Rorer, Sanofi and Famar Lyon, France and Eczacıbaşı İlaç, Turkey. It also goes under the

who last rode alongside his twin brother Alexander Efimkin on Team Type 1–Sanofi. He had established himself as a solid all-around cyclist. In 2005, his

Points  Alessandro Bazzana (Italy) (Team Type 1–Sanofi) Mountains  Georg Preidler (Austria) (Team Type 1–Sanofi) Youth  Angelo Pagani (Italy) (Colnago–CSF

road racing between 2008 and 2021 for the Jelly Belly–Kenda, Team Type 1–Sanofi, UnitedHealthcare and Trek–Segafredo teams. Reijnen was born in Bainbridge

and 2012 for the Barloworld, Quick-Step, Ag2r–La Mondiale and Team Type 1–Sanofi teams. Efimkin has also worked as the directeur sportif of the Russian Helicopters

older, egg-based H5N1 vaccines for humans that have been licensed are: Sanofi Pasteur's vaccine approved by the United States in April 2007, GlaxoSmithKline's

formulation marketed in the United States is Pentacel, manufactured by Sanofi Pasteur. Pentacel is known in the UK and Canada as Pediacel. An equivalent

soon formed, and composed of seven riders: Rubens Bertogliati (Team Type 1–Sanofi), David Boucher (Omega Pharma–Lotto), Will Clarke (Leopard Trek), Sébastien

doctoral programmes in pharmaceutical sciences. On 2016 Institute pact with Sanofi India to promote academic excellence and research in the areas of pharmaceuticals

on 6 February 2016, retrieved 29 January 2016 "Sanofi Pasteur Product Monograph – Immucyst" (PDF). Sanofi Pasteur Canada. Archived (PDF) from the original

cyclist, who rode professionally between 2011 and 2021 for Team Type 1–Sanofi, Team La Pomme Marseille 13 and Xelliss–Roubaix–Lille Métropole. 2006 1st

Cofidis FDJ Saur–Sojasun Skil–Shimano Team Europcar Team NetApp Team Type 1–Sanofi Aventis Veranda's Willems–Accent UCI Continental Teams BigMat–Auber 93 Endura

years 8 8 2.5 – Daptacel Sanofi Pasteur 6 weeks to 7 years 10 5 3 5 Adacel Sanofi Pasteur 11 to 64 years 2.5 5 3 5 Pediacel Sanofi Pasteur 6 weeks to 4 years

in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB. TriHIBit

Geox–TMC Cofidis Topsport Vlaanderen–Mercator Team Europcar Team Type 1–Sanofi UCI Continental Teams Team Concordia Glud & Marstrand-LRØ Rådgivning Christina

owners of the Institut Mérieux holding, founders of companies such as Sanofi Pasteur, bioMérieux (in vitro diagnostics) and Mérial (veterinary activity)

Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm

replicate and cause disease in humans. U.S. Army researchers agreed to give Sanofi permission to develop the technology, but protest in Congress halted the

(Ty21a), or six months (TCV). Vi capsular polysaccharide vaccine: Typhim VI (Sanofi Pasteur); Typherix (GSK) Ty21a oral vaccine: Vivotif (Emergent BioSolutions)

Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation". www.fondation-sanofi-espoir.com. Retrieved 2020-12-14. Jean-Christophe

by Sanofi Pasteur. On 28 April 2022, Sanofi announced it had discontinued a trial evaluating four HSV-2 vaccines. The pipeline section of the Sanofi website

CGT and other worker unions, as well as workers at companies including Sanofi, Cargill, SKF, and General Electric, protested against layoffs; members

obligated to send a squad. Two other squads – SpiderTech–C10 and Team Type 1–Sanofi – were given wildcard places into the race, and as such, formed the event's

formulations include Hexavac, Hexaxim, Hexyon, and Vaxelis manufactured by Sanofi Pasteur. There is a two-part formulation known in abbreviated form as DTaP-IPV-HepB/Hib

Champion System SpiderTech–C10 Bissell Optum–Kelly Benefit Strategies UCI Continental Teams Team Exergy EPM–UNE Team Type 1–Sanofi Bontrager–Livestrong

COVAX-19, EpiVacCorona, IndoVac, MVC-COV1901, Noora, Novavax, Razi Cov Pars, Sanofi–GSK, Sinopharm CNBG, Skycovione, Soberana 02, Soberana Plus, V-01, and ZF2001

Novavax US 20 December 2021 Pending CureVac Germany Pending Pending Valneva France Pending Pending Sanofi–GSK France/UK Pending Pending Total 8.7 million

the U.S., while Yeda and Sanofi-Aventis co-own the 866 Patent's foreign counterparts. Following the ruling, ImClone and Sanofi-Aventis agreed to settle

Project 1t4i Rabobank RadioShack–Nissan Team Saxo Bank Team Sky Team Type 1–Sanofi Utensilnord–Named Vacansoleil–DCM Lowe, Felix (17 March 2012). "Glorious

the causative agent of paratyphoid fever C. Typhim VI (manufactured by Sanofi Pasteur) Typherix (manufactured by GlaxoSmithKline) A newer conjugate form

Felviten Halpen Hepasulfol - Franco-Indian Pharmaceuticals Heporal Mucinol - Sanofi-Aventis Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma

Award, Cancer Research Institute, 2007 Gairdner International Award, 2012 Sanofi-Institut Pasteur Award, 2012, Honorary Doctorate, Friedrich-Alexander-University

licensing agreement with multinational pharmaceutical companies such as Sanofi (Paris, France) and Stendhal (Mexico City, Mexico) for 104 countries. Currently

within the "cocoon". Brand names in the United Kingdom include Revaxis (Sanofi Pasteur). As of January 2020[update], there are six DTaP vaccines and two

vaccine is not patented and is planned to be openly licensed under COVAX. Sanofi–GSK COVID-19 vaccine "A prospective open label randomised phase-I seamlessly

within the "cocoon". Brand names in the United Kingdom include Revaxis (Sanofi Pasteur). As of January 2020[update], there are six DTaP vaccines and two

Liquigas–Cannondale UCI Professional Continental Teams Project 1t4i Team Type 1–Sanofi Colnago–CSF Bardiani Farnese Vini–Selle Italia Team NetApp Acqua & Sapone

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

vaccine (the Nakayama and/or Beijing-1 strain), made by BIKEN and marketed by Sanofi Pasteur as JE-VAX, until production ceased in 2005. The other was an inactivated

the managing partner of the Sanofi Biogenius Canada Competition. The executive director of PIR is Brent Peltola. Sanofi Biogenius Canada VROC "Partners

Championship  United States 1.HC  Alexander Serebryakov (RUS) Team Type 1–Sanofi 12–17 June Tour de Beauce  Canada 2.2  Rory Sutherland (AUS) UnitedHealthcare

2019. "Sanofi: FDA advisory committee votes on Zynquista (sotagliflozin) as treatment for adults with type 1 diabetes" (Press release). Sanofi. 17 January

collaborations with organizations, including agreements with Boehringer Ingelheim, Sanofi Pasteur, Johnson & Johnson, Genmab, the Bill & Melinda Gates Foundation

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

p. 355. ISBN 9780781733717. Archived from the original on 2016-12-20. "Sanofi-Aventis Bekräftigt Seine Verpflichtung Zur Sicherstellung Des Zugangs Zu

to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi. "US Sargramostim label" (PDF). FDA. March 2018. Retrieved 30 March 2018

Mondiale Euskaltel–Euskadi Team Europcar Colombia–Coldeportes Saur–Sojasun Project 1t4i Bretagne–Schuller Team Type 1–Sanofi La Pomme Marseille Auber 93

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Neurology segment when it entered into a strategic marketing partnership with Sanofi. In 2014, Lupin acquired 100% equity stake in Laboratories Grin, S.A. De

pharmaceutical entities across the globe, such as Merck & Co. (U.S.A.), Sanofi Pasteur MSD (France) and Takeda Pharmaceutical Company Limited (Japan).

development branch of the institute was separated early on and is now part of Sanofi Pasteur.,, The current name was changed in 2009 from Mérieux Alliance. The

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

which falls within the claim. In Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., it was claimed that Sanofi-Synthelabo’s patent was invalid because it covered

Janssen 11 March 2021 23 April 2021 Novavax 20 December 2021 Not yet Valneva Pending Not yet Sanofi–GSK Pending Not yet CureVac  Request withdrawn No

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

for vaccine usage and effectiveness surveillance had started. In 2009, Sanofi-Pasteur started building a new facility in Neuville-sur-Saône' (fr), a suburb

Retrieved 2009-09-24. "Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV" (PDF). Sanofi Pasteur. Retrieved

Garikoitz Bravo Caja Rural Tarik Chaoufi neo-pro Jure Kocjan Team Type 1–Sanofi Juan José Lobato Andalucía Ricardo Mestre Carmim–Prio Steffen Radochla Team

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Professional, XL Energy, Abbott, B. Braun, Eli Lilly, GlaxoSmithKline, Sanofi Aventis and Nivea, among many others. APIC is located in Amman, Jordan and

Hybritech, Inc. from Eli Lilly. In 1996, the company acquired the Sanofi portion of Sanofi Pasteur Diagnostics. In 1998, the company acquired Coulter Corporation

Saur–Sojasun Team Saxo Bank Team Sky Topsport Vlaanderen–Mercator Team Type 1–Sanofi Vacansoleil–DCM "Rodriguez wins La Flèche Wallonne". Cycling News. Future

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Yes Yes Moderna Yes Yes Janssen Yes Yes Sputnik V Yes Yes Convidecia Yes No Novavax Yes No Sanofi–GSK Pending No CureVac Pending No Valneva Pending No

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

February 2021 Janssen 11 March 2021 Yes Novavax 20 December 2021 Pending Valneva Pending Pending Sanofi–GSK Pending Pending CureVac  Request withdrawn No

2003 Nippon Hodo 2004 Nippo 2005–2010 Ceramica Flaminia 2011– Team Type 1–Sanofi Aventis Major wins Trofeo Melinda (1994) Giro di Toscana (1995) GP Industria

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Farnese Vini–Selle Italia's Rafael Andriato, Martijn Verschoor of Team Type 1–Sanofi and Ángel Madrazo, representing the Movistar Team and the quartet managed

infection. ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur in 2008, before selling the smallpox vaccine to Emergent Biosolutions

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

as numerous lawsuits with changing outcomes on appeal illustrate (e.g. Sanofi-Aventis GmbH v. Glenmark Pharmaceuticals, 748 F. 3d 1354 (Fed. Circuit 2014))

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

der Zulassung Tetrazepam haltiger Arzneimittel in der EU (German)" (PDF). Sanofi-Aventis Deutschland GmbH. Archived from the original (PDF) on 27 September

der Zulassung Tetrazepam haltiger Arzneimittel in der EU (German)" (PDF). Sanofi-Aventis Deutschland GmbH. Archived from the original (PDF) on 27 September

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Finn & Egan 2018, p. 76. "IPOL Inactivated Poliomyelitis Vaccine" (PDF). Sanofi Australia & New Zealand. Archived (PDF) from the original on 10 September

SpiderTech–C10* Team Europcar* Team Katusha Team NetApp* Team Sky Team Type 1–Sanofi* Topsport Vlaanderen–Mercator* Vacansoleil–DCM Pre-race favourites included:

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Road Race  Eritrea CC  Natnael Berhane (ERI) Eritrea (national team) 20–27 November Tour of Rwanda  Rwanda 2.2  Kiel Reijnen (USA) Team Type 1–Sanofi

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Long Haul v Regents of the University of California Medical Week News v. Sanofi-Aventis Merkey v. Yahoo SCOX, Groklaw et. al. Mobilisa v. Doe MPAA v. The

Démare (FRA) FDJ–BigMat s.t. 5  Alexander Serebryakov (RUS) Team Type 1–Sanofi s.t. 6  Tom Veelers (NED) Project 1t4i s.t. 7  Sébastien Chavanel (FRA)

deathstalker envenomations is produced by pharmaceutical companies AbbVie and Sanofi Pasteur, and by the National Antivenom and Vaccine Production Center in

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Retrieved May 23, 2020. ""Sanofi Awarded $226 million by US Government to Expand Pandemic Influenza Preparedness"". www.news.sanofi.us. December 9, 2019.

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

President of the Canadian Society for Immunology and from 2009 to 2019 held the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. Tania Watts

Teklehaimanot Eritrea national team 2011  United States Kiel Reijnen Team Type 1–Sanofi 2012  South Africa Darren Lill South Africa national team 2013  South Africa

therapy technology. The firm had already established collaborations with Sanofi, Novartis and other groups to provide lentiviral vector manufacturing. In

gambiense sleeping sickness on 28 November 1990. However, in 1995 Aventis (now Sanofi-Aventis) stopped producing the drug, whose main market was African countries

role during 2015–19 as a consultant and later as a scientific critic of Sanofi Pasteur’s Dengvaxia, the first dengue vaccine to be licensed for widespread

original on August 28, 2021. Retrieved August 27, 2021. "Insulin aspart Sanofi EPAR". European Medicines Agency (EMA). April 28, 2020. Archived from the

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Professional teams 2010 Mountain Khakis–Jittery Joe’s 2011–2012 Team Type 1–Sanofi Aventis 2013–2014 Hincapie Sportswear Development Team 2015–2020 BMC Racing

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

2007. IPOL, developed by Sanofi Pasteur, was approved by the Food and Drug Administration in 1987. Verorab, developed by Sanofi Pasteur, is a mammalian

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Sciences Alliance, which Jones also co-founded. In 2010, Jones was named to Sanofi-Aventis Pharmaceuticals’ Archived 2011-08-07 at the Wayback Machine Consumer

Trek Adecco Professional teams 2009–2011 Joker–Bianchi 2012 Team Type 1–Sanofi 2013–2014 Bretagne–Séché Environnement 2015 Team Joker 2016 IAM Cycling

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Feillu (FRA) Vacansoleil–DCM + 2' 43" 4  Jure Kocjan (SLO) Team Type 1–Sanofi Aventis + 2' 43" 5  Arthur Vichot (FRA) FDJ + 2' 43" 6  Cyril Gautier (FRA)

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

by efficacy question mark, Chemistry World, Maria Burke, 29 July 2015 Sanofi's Dengue Vaccine Dengvaxia Gains Brazilian Approval, Zacks Equity Research

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Carmiooro A Style 2010 Ceramica Flaminia 2011 Geox–TMC 2012 Team Type 1–Sanofi 2013–2014 Vini Fantini–Selle Italia 2015–2016 Nippo–Vini Fantini 2017 Qinghai

the Federal State Unitary Enterprise of Chumakov Institute in Russia, and Sanofi Pasteur, the French pharmaceutical company. Two other manufacturers supply

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Corporation* 88.9 AstraZeneca Canada Inc. (fs) 79.8 Sanofi Pasteur Limited (fs) 76.6 QLT Inc.* 74.6 MDS Inc. 71.8 Sanofi-aventis Canada Inc. (fs) 59.6 Vasogen Inc

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

UCI Professional Continental Teams SpiderTech–C10 Geox–TMC Team Type 1–Sanofi * UnitedHealthcare * (* – participated in 2010) UCI Continental Teams Bissell

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Ther., 1981, 16, 431, 439. Pierre Simon & Jacques Dreux, U.S. patent 4,287,206 (1981 to Sanofi Aventis France). 시몽 삐에르 & 드로 짝끄, KR830002288 (1983). v t e

Wayback Machine. "Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV" (PDF). Sanofi Pasteur. Archived

Medal, International Union of Biochemistry and Molecular Biology 2016 – Sanofi-Pasteur International Mid-career Award 2016 – Elected Fellow, American Academy

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Sprinter Professional teams 2007–2008 Successfulliving.com–Parkpre 2009–2010 Fly V Australia 2011–2012 Team Type 1–Sanofi Aventis 2013–2015 UnitedHealthcare

Agency (EMA) issued a marketing authorization for the zoster vaccine to Sanofi Pasteur for routine vaccination in individuals aged 60 and over. In 2007

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Medal, International Union of Biochemistry and Molecular Biology 2016 – Sanofi-Pasteur International Mid-career Award 2016 – Elected Fellow, American Academy

20 December 2021 Pending Pending Valneva Pending Pending Pending Pending Sanofi–GSK Pending Pending Pending Pending CureVac  Request withdrawn  Request

1325311. PMID 28475455. "Sanofi Receives FDA Approval of Soliqua 100/33, for the Treatment of Adults with Type 2 Diabetes". Sanofi. November 21, 2016. Archived

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

August 2014, PATH and Sanofi announced the release of the first batch of semisynthetic artemisinin. 1.7 million doses of Sanofi's ArteSunate AmodiaQuine

Innovative Medicines Canada, Medicago, Merck, Pfizer, Public Health Ontario, Sanofi Pasteur, Seqirus and Valneva SE. Notable presenters include Dr. Shelley

Radenska–Rog 2008 Perutnina Ptuj 2009–2010 Carmiooro A Style 2011–2012 Team Type 1–Sanofi Aventis 2013 Euskaltel–Euskadi 2014–2015 Team SmartStop 2016 Lupus Racing

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

21–5. doi:10.1111/ijcp.12054. PMID 23163544. S2CID 205184492. "Combiflam". Sanofi India. 28 February 2023. Archived from the original on 3 March 2023. Retrieved

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Widens as Sanofi Pulls Its Drug Over Carcinogen Fears". The New York Times. Retrieved July 4, 2022. Nate Raymond (October 7, 2021). "Sanofi, GSK can't

regional headquarters in Nairobi, Kenya include: Danone, Alcatel, Alstom Grid, Sanofi, Veritas, Ceva Animal Health, Thales, Michelin, Sagem and Egis group. Nairobi

February 2021 Janssen 11 March 2021 Yes[when?] Novavax 20 December 2021 Pending CureVac Pending Pending Valneva Pending Pending Sanofi–GSK Pending Pending

February 2024. Retrieved 8 March 2024. "Information on Dengvaxia®". www.sanofi.com. Archived from the original on 8 March 2024. Retrieved 8 March 2024

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

"Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi". PharmaDeals Review. No. 7. doi:10.3833/pdr.v2011i7.1494 (inactive 1 November

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Jamis–Sutter Home, Timon Seubert of Team NetApp and László Bodrogi of Team Type 1–Sanofi Aventis were later joined by Bissell's Ben Jacques-Maynes as they extended

became available to the public in Canada or elsewhere. In Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., the Supreme Court of Canada affirmed the test for

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

Goldsmith, 598 U.S. 508 October 12, 2022 May 18, 2023 24 Amgen Inc. v. Sanofi, 598 U.S. 594 March 27, 2023 May 18, 2023 25 Gonzalez v. Google LLC, 598

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

2004–2008 Saunier Duval–Prodir 2009–2010 Diquigiovanni–Androni 2011–2012 Team Type 1–Sanofi Aventis Major wins Tour de France, 1 stage GP Chiasso (2001)

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

throughout Europe, Asia and South America. In 2003, the drug was withdrawn by Sanofi-Synthélabo, after reports of serious hepatotoxicity, although it is still

Professional teams 2010 RC Arbö–Gourmetfein–Wels 2011 Tyrol Team 2012 Team Type 1–Sanofi 2013–2017 Argos–Shimano 2018–2019 FDJ Major wins One-day races and Classics

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

on 4 March 2016. Retrieved 21 October 2014. "Growth platforms". sanofi.co.uk. Sanofi. Retrieved 24 October 2014. L. Laurie, Donald; L. Doz, Yves; P. Sheer

mixed but mostly negative Phase 3 trial results in 2009, and abandoned by Sanofi-Aventis GR-159897 MEN-10376 - potent and selective antagonist, 7-amino acid

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

However, Sanofi dropped its own vaccine after it acquired Acambis in 2008. ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur

East Anglian Daily Times. 11 January 2018. Retrieved 27 December 2018. Sanofi-Aventis Archived 29 September 2007 at the Wayback Machine UK home page Fisons

intellectual property developed at the institute, such as Alnylam Pharmaceuticals, Sanofi Genzyme, Ironwood Pharmaceuticals, Rubius Therapeutics, and Verastem. In

Professional teams 2011 Androni Giocattoli (stagiaire) 2012 Team Type 1–Sanofi 2013–2014 Bardiani Valvole–CSF Inox 2015–2016 GM Europa Ovini 2017 Tirol

also asserted that one of the drug companies that lobbied for PREPA is Sanofi Pasteur, which was under Food and Drug Administration (FDA) investigation

specifically address the eight Wands factors in its decision in Amgen Inc v. Sanofi. However, the Court stated that the specification may call for a reasonable

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

flew in 2006 and was less than eight years old. The airplane was owned by Sanofi-Aventis Groupe SA but operated by Unijet, which specializes in business

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

British Society for Parasitology C. A. Wright Memorial Medal, the 2015 Sanofi Pasteur International Research Award for his contributions to infectious

SpiderTech–C10 Argos–Shimano Team NetApp Saxo Bank–Tinkoff Bank Team Type 1–Sanofi Topsport Vlaanderen–Mercator Vacansoleil–DCM Wallonie Bruxelles–Crédit Agricole

Pharma–Quick-Step Rabobank RadioShack–Nissan Saur–Sojasun* Team Europcar* Team Saxo Bank Team Sky Team Type 1–Sanofi* Topsport Vlaanderen–Mercator* Vacansoleil–DCM

2005–2008 Crédit Agricole 2009–2010 Team Katusha 2011–2012 Team Type 1–Sanofi Aventis Major wins Stage races Tour de Luxembourg (2005) One-day races and

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

On hold Novavax 2.2 million 20 December 2021 Pending Pending CureVac 4.5 million Aborted Aborted Aborted Sanofi–GSK 4.9 million Pending Pending Pending

(CJR) Endura Racing (EDR) RusVelo (RVL) Plussbank BMC (PBC) Team Type 1–Sanofi (TT1) Team Cykelcity (CyC) Topsport Vlaanderen–Mercator (TSV) Team Øster

(stagiaire) 2011 Type 1 Development Professional teams 2011 Team Type 1–Sanofi (stagiaire) 2012–2015 BMC–Hincapie Sportswear Team 2016 UnitedHealthcare

2009 Cemelorca–Trek–Lorca Taller del Tiempo 2010–2012 Esteve Bicicletas 2012 Team Type 1–Sanofi (stagiaire) Professional team 2013– Team Novo Nordisk

Express A Pocono Country Place St. Luke's Hospital Mt. Pocono Walmart, Sanofi Pasteur, Pocono Premium Outlets, Northampton Community College Monroe Campus

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial

EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial